Search results
Results from the WOW.Com Content Network
On March 20, 2024, Neuralink introduced the person who had received the first Neuralink implant in the clinical trial as 29-year-old Noland Arbaugh through a livestream on X. Arbaugh had become a quadriplegic after experiencing a diving accident dislocated his C4 and C5 spinal vertebrae. Later in the livestream, Noland demonstrated his ability ...
For premium support please call: 800-290-4726 more ways to reach us
This trial is expected to enroll three patients to evaluate its device in a study expected to take several years to complete, according to details on the U.S. government's clinical trials database.
Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the ...
Noland Arbaugh (born 1993 or 1994) is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. [1] He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
In 2020, scientists out of the University of Melbourne, who formed the company Synchron in 2016, published clinical data related to a discovery for Stentrode, a device implanted via the jugular vein, without the need for open brain surgery. The technology was shown to enable two patients to control a computer using thought alone.
Some of the staff at Elon Musk's Neuralink are making preparations to sell the brain implant company's stock in the wake of its valuation jumping following its first human trial, according to ...
Expanded access or compassionate use is the use of an unapproved drug or medical device under special forms of investigational new drug applications (IND) or IDE application for devices, outside of a clinical trial, by people with serious or life-threatening conditions who do not meet the enrollment criteria for the clinical trial in progress.